Increased susceptibility to Streptococcus pneumoniae pulmonary infection in the Eμ-TCL1 adoptive transfer mouse model of CLL

被引：0
|
作者：
Colado, Ana
Bernatowiez, Juliana
Cassarino, Chiara
Martinez, Valeria Sarapura
Bertini, Martin
Bezares, Fernando R.
Vermeulen, Monica
Gamberale, Romina
Giordano, Mirta
Borge, Mercedes
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1551267
引用
收藏
页码：S182 / S183
页数：2
相关论文
共 50 条
  • [1] Age and Sex Differences in the Eμ-TCL1 Adoptive Transfer Mouse Model of CLL
    Sharpe, Chia
    Perry, Elizabeth
    Hertlein, Erin
    Muthusamy, Natarajan
    Byrd, John C.
    BLOOD, 2022, 140 : 12367 - 12368
  • [2] Immune Checkpoint Blockade with Anti-PD-L1 Prevents Immune Dysfuntion and CLL Development in the TCL1 Adoptive Transfer Mouse Model
    Hanna, Bola
    McClanahan, Fabienne
    Clear, Andrew James
    Miller, Shaun
    Lichter, Peter
    Seiffert, Martina
    Gribben, John G.
    BLOOD, 2014, 124 (21)
  • [3] The Nature of the Antigen Determines Leukemia Development and Behavior in the Eμ-TCL1 Transgenic Mouse Model of CLL
    Bennardo, Sara
    Iacovelli, Stefano
    Gobessi, Stefania
    Suljagic, Mirza
    Bilbao, Daniel
    Eckl-Dorna, Julia
    Wang, Hongsheng
    Cornall, Richard J.
    Clarke, Stephen H.
    Croce, Carlo M.
    Efremov, Dimitar G.
    BLOOD, 2012, 120 (21)
  • [4] AID Contributes to Accelerated Disease Progression in the TCL1 Mouse Transplant Model for CLL
    Schubert, Maria
    Gassner, Franz Josef
    Huemer, Michael
    Hoepner, Jan Philip
    Akimova, Ekaterina
    Steiner, Markus
    Egle, Alexander
    Greil, Richard
    Zaborsky, Nadja
    Geisberger, Roland
    CANCERS, 2021, 13 (11)
  • [5] CLL INDUCES SEVERE SKEWING IN THE MYELOID COMPARTMENT IN PATIENTS AND IN THE TCL1 MOUSE MODEL
    Hanna, B.
    McClanahan, F.
    Zaborsky, N.
    Duerr, C.
    Gschwend, V.
    Stilgenbauer, S.
    Egle, A.
    Gribben, J.
    Lichter, P.
    Seiffert, M.
    HAEMATOLOGICA, 2014, 99 : 228 - 229
  • [6] Btk Inhibitor, PCI-32765, Delays CLL Progression in a TCL1 Adoptive Transfer Model by Impairing Migration and Cell Proliferation
    Chen, Shih-Shih
    Buggy, Joseph J.
    Chang, Betty Y.
    Burger, Jan A.
    Chiorazzi, Nicholas
    BLOOD, 2011, 118 (21) : 449 - 449
  • [7] In vivo application of the lipase inhibitor orlistat suppresses chronic lymphocytic leukemia (CLL) in an Eμ-TCL1 transgenic mouse model
    Pallasch, C. P.
    Schneider, P.
    Frenzel, L. P.
    Reinart, N.
    Taubert, D.
    Schwamb, J.
    Fingerle-Rowson, G.
    Wendtner, C-M
    ONKOLOGIE, 2010, 33 : 184 - 184
  • [8] Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL
    Iacovelli, Stefano
    Hug, Eva
    Bennardo, Sara
    Duehren-von Minden, Marcus
    Gobessi, Stefania
    Rinaldi, Andrea
    Suljagic, Mirza
    Bilbao, Daniel
    Bolasco, Giulia
    Eckl-Dorna, Julia
    Niederberger, Verena
    Autore, Francesco
    Sica, Simona
    Laurenti, Luca
    Wang, Hongsheng
    Cornall, Richard J.
    Clarke, Stephen H.
    Croce, Carlo M.
    Bertoni, Francesco
    Jumaa, Hassan
    Efremov, Dimitar G.
    BLOOD, 2015, 125 (10) : 1578 - 1588
  • [9] Pan-omics assessment of constitutive AKT-activation in the Eμ-TCL1 CLL-like mouse model
    Blakemore, S. J.
    Kohlhaas, V.
    Al-Maarri, M.
    Knittel, G.
    Reinhardt, C.
    Hallek, M.
    Peifer, M.
    Wunderlich, T.
    Pallasch, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 18 - 18
  • [10] Genetic Loss of NFAT2 Induces Profound Acceleration of CLL in the TCL1 Mouse Model
    Maerklin, Melanie
    Bugl, Stefanie
    Heitmann, Jonas S.
    Poljak, Alexandra
    Hackl, Bettina S.
    Kopp, Hans-Georg
    Kanz, Lothar
    Rao, Anjana
    Wirths, Stefan
    Mueller, Martin R.
    BLOOD, 2012, 120 (21)
12345